Atypical Wounds Atypical Wounds: Session Description Sufficient - - PowerPoint PPT Presentation

atypical wounds atypical wounds session description
SMART_READER_LITE
LIVE PREVIEW

Atypical Wounds Atypical Wounds: Session Description Sufficient - - PowerPoint PPT Presentation

Kara S. Couch MS, CRNP, CWCN-AP (subbing for Kimberly Thomas DNP) Director, Inpatient Wound Care George Washington University Hospital Atypical Wounds Atypical Wounds: Session Description Sufficient high-quality evidence is limited for


slide-1
SLIDE 1

Kara S. Couch MS, CRNP, CWCN-AP (subbing for Kimberly Thomas DNP) Director, Inpatient Wound Care George Washington University Hospital

Atypical Wounds

slide-2
SLIDE 2

Atypical Wounds: Session Description

  • Sufficient high-quality evidence is limited

for wounds that are considered atypical.

  • This session will provide an overview

about recognizing and diagnosing wounds considered atypical.

slide-3
SLIDE 3

Background

  • Prevalence of atypical wounds can be as high

as 10 % (lower extremity) to 20 % of all wounds

  • Probable many of these underdiagnosed
  • Atypical wound=do not fall into typical wound

pattern (venous, arterial, mixed, pressure injury, diabetic foot ulcer)

slide-4
SLIDE 4

Treatment Delays

  • Limited training/education of health

professionals

  • Lack of structured credentials for health

professionals specializing in wound care

  • Limited existence of best practice

guidelines/protocols

slide-5
SLIDE 5

Impact to Patients

  • Travel to and payment to specialists
  • Work absence/capacity to work
  • Time and cost diagnostic testing
  • Wound dressings/products/medications cost
  • Quality of Life
  • Social detriments/isolation
slide-6
SLIDE 6

Economics of Atypical Wounds

  • Exact costs unknown; included as chronic

wound data

  • Delayed diagnosis = delayed treatment &

increased cost

  • Limited clinical research
  • Limited specific diagnostics
slide-7
SLIDE 7

Atypical Wounds Description

  • Suspect Atypical Wound:

– Appearance of wound is unusual or different than expected for typical wound type

  • Irregular wound edges
  • Inconsistent wound tissue (some areas flat, some areas hypertrophic)
  • Wound bed with mixed or unidentifiable tissue base

– Abnormal presentation or location

  • Particularly multiple wounds in unusual location(s)

– Pain not consistent with presentation – Wound does not progress within 4-12 weeks with appropriate treatment

slide-8
SLIDE 8

Background

Atypical wounds may be related to: –Inflammation –Infection –Malignancy –Chronic illness –Metabolic –Vasculopathies –Genetic disease –Miscellaneous

slide-9
SLIDE 9

Diagnostics

  • Thorough patient history/wound history

– Neurovascular assessment

  • Wound Assessment

– Location – Precipitating factors (trauma vs. spontaneous) – Tissue quality – Peri-wound skin – Pain (disproportionate) – Skin discolorations – Timing of wound progression

slide-10
SLIDE 10

Diagnostics

  • Wound without progress in 4-12 weeks

consider suspicious –At least 1 biopsy, 2 preferable (skin edge + wound bed) –Suspected infection, wide biopsy with tissue culture

slide-11
SLIDE 11

Diagnostics

  • Biopsy

– Wounds with unknown causes – Helps narrow down/confirm diagnosis for atypical wound

  • Unusual appearing lesions
  • Inflammatory Skin Condition
  • Bullous Skin Condition
  • Suspect tumor/skin cancer
slide-12
SLIDE 12

Algorithm for Diagnosing Atypical Wounds

slide-13
SLIDE 13

Atypical Wounds: Inflammatory

Pyoderma Gangrenosum

– Cutaneous manifestation of general inflammatory response – Exact etiology unknown – 50% of patients have associated disease

  • Inflammatory bowel disease
  • Inflammatory rheumatological disease
  • Neoplasia
  • Metabolic syndrome

– 70-80% PG cases occur on lower extremities

slide-14
SLIDE 14

Atypical Wounds: Inflammatory

Pyoderma Gangrenosum

  • Clinical Signs

– Start as pustular/bullous lesions and become necrotic – Ulcer edges are unattached, violaceous, overhanging, peripheral zone erythema – Rapid expansion, irregular, painful

  • Treatment

– Treatment

  • Biopsy and debride (sharp or enzymatic) with caution (pathergy can exacerbate)
  • Biopsy does not confirm PG
  • Supportive wound care. No curative treatment.

– Topical intralesional steroid injection, tacrolimus – Systemic glucocorticoids, antibiotics, immunosuppressant, biologics – Limited research into surgical intervention with aggressive wide excision, NPWT, HBOT (last resort)

slide-15
SLIDE 15

Peri-stomal Pyoderma Gangrenosum

woundcareadvisor.com

slide-16
SLIDE 16

Atypical Wounds: Inflammatory

Vasculitis

– Inflammation resulting in vessel occlusion causing blood vessel wall damage (necrosis) – Idiopathic

  • Infection
  • Malignancies
  • Medications
  • Connective tissue disorders
slide-17
SLIDE 17

Atypical Wounds: Inflammatory

Vasculitis

  • Clinical Signs

– Categorized into small, medium, large vessel vasculitis disease

  • Small vessel: livedo reticularis-forked lightening appearance
  • Medium vessel: necrotic lesions/bullae, may be nodular
  • Large vessel: nodular lesions
  • Treatment
  • Supportive wound care
  • Varying literature NSAIDs, steroids, immunosuppressants, antihistamines
  • Consider referral to vascular specialist, rheumatology, internal medicine dermatology for

systemic treatment

slide-18
SLIDE 18

Large Vessel (Nodular)

plasticsurgerykey.com

semanticscholar.org

Vasculitis

vasculitis.uk.org

slide-19
SLIDE 19

Atypical Wounds: Vasculopathies

Vasculopathies

  • Blood vessel disorder causing complete occlusion of the vessel
  • Thrombus results in tissue hypoxia and dermal necrosis
  • Does not include primary inflammation
  • Categorized into 3 major groups:

– Embolization – Intravascular thrombi – Coagulopathies

slide-20
SLIDE 20

Atypical Wounds: Vasculopathies

Vasculopathies

  • Clinical signs

– Purpura, ulcers, infarcts, ”purple toe syndrome” – Violaceous painful, necrotic/ulcerated lesions may involve

  • ther organs (cerebrovascular, renal, visceral)
  • Treat

– Supportive wound care – Pain management – Thorough diagnostics-treat predisposing factors

slide-21
SLIDE 21

Livedoid Vasculopathy aka Atrophie Blanche

scielo.br.com

slide-22
SLIDE 22

Atypical Wounds: Infectious

Variety of infections can cause atypical ulcer presentation

– Atypical bacteria – Mycobacterial – Fungal – Tropical ulcer – Necrotizing Fasciitis

  • Dx by pathology
  • Acute wound, surgical problem
  • Clinical Signs

– Variable – Patient history is key

  • Treat

– Culture and Swab: bacterial and mycologic – Supportive wound care – Treat systemically per results

slide-23
SLIDE 23

Atypical Wounds: Metabolic

Calciphylaxis & Martorell Hypertensive Ischemic Leg Ulcer (HYTILU)

– Calcific uremic arteriolopathy – Skin infarction and acral gangrene r/t ischemic arteriolosclerosis – Vascular, cutaneous, subcutaneous calcification causing tissue hypoxia/necrosis

slide-24
SLIDE 24

Atypical Wounds: Metabolic

Calciphylaxis & Martorell (HYTILU)

  • Clinical signs

– Dusky discoloration, violaceous plaque becomes rapidly necrotic – Lesions irregular edges, polycyclic, inflamed border, undermined, extremely painful, lesion groups follow distinct pattern – Distal skin infarction (laterodorsal/achilles tendon) – Proximal/Central (thighs, abdominal fatty apron/pannus, breasts, upper arms) – Acral gangrene (fingers, toes, penis)-Calciphylaxis only

slide-25
SLIDE 25

Atypical Wounds: Metabolic

Calciphylaxis & Martorell HYTILU

  • Differentiation:

– Classic Calciphylaxis-ESRD

  • Rarely in patients without ESRD w/ morbid obesity + essential

hypertension + diabetes

  • 1 year mortality with ESRD 40-50%

– HYTILU-No ESRD

  • 100% Essential hypertension +/- Diabetes
  • 1 year mortality without ESRD 25%
slide-26
SLIDE 26

Atypical Wounds: Metabolic

Calciphylaxis & Martorell HYTILU

  • Treatment

– Surgical

  • Aggressive wound management. Excision with grafting/NPWT.
  • Amputation

– Supportive wound care – Antibiotics – Nephrology collaboration: medication management w/dialysis and diet modifications – Pain management – Thorough diagnostics-treat predisposing factors

slide-27
SLIDE 27

Calciphylaxis

semanticscholar.org

HYTILU

scielo.br.com

slide-28
SLIDE 28

Non-Uremic Calciphylaxis

slide-29
SLIDE 29

Early June 2018 June 19, 2018

slide-30
SLIDE 30

July 24, 2018 Sept 10, 2018

slide-31
SLIDE 31

Atypical Wounds: Malignant

Malignancies

– Malignancy in leg ulcers 2-4% – Classified 2 categories

  • Primary ulcerating skin tumor (basal cell, squamous cell)

– 60-80% cases on head/neck

  • Secondary ulcerating skin tumors (malignancies develop

from chronic ulcerations)-Marjolin’s ulcer

  • Ulcerating skin tumors uncommon
slide-32
SLIDE 32

Atypical Wounds: Malignant

Malignancies

  • Clinical signs

– Clinical presentation varies widely-often look like typical ulcerations – Suspicious: excessive granulation tissue (especially at edge), irregular borders, odor, increased pain and bleeding, change in appearance of chronic ulcer, delay in healing despite appropriate treatment

  • Treat

– Skin biopsy (2 site) – Confirmed malignancy-appropriate referral for treatment (surgery, plastics, dermatology, oncology)

slide-33
SLIDE 33

Basal Cell

Primarycaredermatology.org.uk

Marjolin’s Ulcer

wikipedia.com

Basal Cell

dermatologyadvisor.com

slide-34
SLIDE 34

Atypical Wounds: Miscellaneous

Artefactual Ulcers

  • Deliberate and conscious production of self-inflicted

lesions/ulcers

  • Satisfies unconscious psychological or emotional

need

  • Most commonly seen during times of increased

stress & underlying psychological disorders

slide-35
SLIDE 35

Atypical Wounds: Miscellaneous

Artefactual Ulcers

  • Clinical signs

– Most common in females in teens to early 20’s – Occurs in mysterious/spontaneous ways – Unusual patterns, sharply demarcated edges – Face, upper trunk, extremities; spares anatomic areas difficult to reach

  • Treat

– Diagnosis of exclusion-histology shows non-specific lesions – Supportive wound care – Psychiatric/psychosocial treatment (psychotropic medications)

slide-36
SLIDE 36

Artefactal Wound

dermatologyadvisor.com

slide-37
SLIDE 37

References

Isoherranen K, Jordan O’Brien J, Barker J et al. (2019). EWMA document; Atypical wounds. Best clinical practice and challenges. Misciali C, Dika E, Fanti PA et al. Frequency of malignant neoplasms in 257 chronic leg ulcers. Dermatol Surg 2013; 39(6):849–854. https:// dx.doi.org/10.1111/dsu.12168 Combemale P, Combemale P, Debure C et al. Malignancy and chronic leg ulcers: the value of systematic wound biopsies: a prospective, multicenter, cross-sectional study. Arch Dermatol 2012; 148(6):704–

  • 708. https://dx.doi.org/10.1001/archdermatol.2011.3362

Niezgoda, J. (2017). Wound care basic training: atypical Wounds. webcme.org Mooij MC, Huisman LC. Chronic leg ulcer: does a patient always get a correct diagnosis and adequate treatment? Phlebology 2016; 31(1_ suppl Suppl):68–73. https://dx.doi.org/10.1177/0268355516632436

slide-38
SLIDE 38

Thank You!

  • secretary@aawconline.org